BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GRIPE - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://gripe.polisci.ucla.edu
X-WR-CALDESC:Events for GRIPE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250416T120000
DTEND;TZID=America/New_York:20250416T133000
DTSTAMP:20260515T055132
CREATED:20250212T220250Z
LAST-MODIFIED:20250410T003843Z
UID:1699-1744804800-1744810200@gripe.polisci.ucla.edu
SUMMARY:Zoe Ge (IE\, presenter) and Mengfan Cheng (NYU)\, Can International Organizations Shape Technology Development?
DESCRIPTION:Abstract: Technology development is unequal. Existing research suggests that the lack of credible and profitable market demand causes such unequal innovations\, leading to the neglect of technologies with low market returns. We study how international organizations (IOs) can mitigate such inequalities. Specifically\, IOs can leverage their central role in global aid procurement and provide information about the potential market demand\, which helps channel investment into neglected technologies. Empirically\, we investigate how the World Health Organization’s (WHO) information provision on vaccine priority can shape R&D investment in infectious diseases. First\, we study how the WHO sets priorities for vaccines. Using disease characteristics to explore the variation in the credibility of market demand across different diseases\, we find that diseases with unequal geographic distribution receive higher priority from the WHO\, while severe diseases are not listed as a high priority\, confirming that the WHO provides information to substitute for the lack of credible market demand. Further\, we evaluate the effects of this priority-setting strategy and find increased market entry of vaccine products listed as a high priority. However\, we do not find increased R&D investment in high-priority diseases. This paper reveals the potential and constraints of information provision by IOs to correct for market failure in technology development.\n\nLink to PDF
URL:https://gripe.polisci.ucla.edu/event/ge-2025-04-09/
CATEGORIES:season12
END:VEVENT
END:VCALENDAR